We read with interest the article by O\'Byrne et al. about the presentation of 2 and review of 35 patients with MTO1-deficiency [@bb0005]. We have the following comments and concerns.

Patient-1 had febrile seizures since age 2.5y and absence seizures since age 3.5y [@bb0005]. Which antiepileptic drugs (AEDs) were administered during the course? This issue is crucial since some AEDs, such as valproic acid, carbamazepine, phenytoin, or phenobarbital may exhibit mitochondrion-toxic effects, and may worsen the phenotype [@bb0010]. Particularly valproic acid may exhibit severe side effects in patients with a mitochondrial disorder (MID) and may even cause death, particularly in patients carrying *POLG1* mutations [@bb0015]. Seizures were refractory to treatment at age 11y [@bb0005]. Was refractoriness attributable to the mitochondrion-toxic effect of the applied AEDs?

At age 11y patient-1 developed multiple, transient T2-hyperintensities within the peduncles, basal ganglia, and the cortex [@bb0005]. Were these imaging abnormalities stroke-like lesions, the morphological equivalent of stroke-like episodes (SLEs)? Did the phenotype deteriorate during this episode? Were these lesions hyperintense on DWI and ADC, thus indicative of a vasogenic edema, typical for a stroke-like lesion? Did the patient receive L-arginine during this episode, which is frequently recommended as acute treatment of SLEs [@bb0020]. Were other causes of the transient T2-hyperintensities, such as ADEM or an epiphenomenon of the seizure activity, considered?

One of the dominant phenotypic features seems to be hypertrophic cardiomyopathy and arrhythmias ([Table 1](#t0005){ref-type="table"}) [@bb0005]. How many of the analysed patients developed heart failure or systolic dysfunction and required cardiac therapy? Was non-compaction, frequently associated with MIDs [@bb0025], detected in any patient?Table 1Phenotypic features in 35 patients carrying MTO1 mutations.Table 1FeatureNumber of patientsBrain Intellectual disability26 Muscle hypotonia22 Failure to thrive15 Abnormal cerebral imaging15 Seizures12 Optic atrophy9 Ataxia7 Developmental delay6 Dystonia1Eyes Cataract1 Pigmentary retinopathy1Heart Hypertrophic cardiomyopathy27 Cardiac arrhythmias8 Dilated cardiomyopathy1Muscle Lactic acidosis20 Myopathy7 Respiratory insufficiency5Endocrine abnormalities Hypoglycemia2 Short stature1Gastrointestinal Feeding difficulties15 Hepatopathy3Renal Hypocalcemia1 Tubulopathy1Others Dysmorphism1 Microcephaly1 Hyper-ammonemia1

Overall, this interesting study could be more meaningful by providing more details about the AED treatment and its influence on the phenotype, about the cerebral imaging findings, about the cardiac involvement in the disease, and about the family history.
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